Insulin delivery with plasmid DNA

Human Gene Therapy

Volumn 10, Issue 16, 1999, Pages 2637-2649

  Abai, Anna M ^a   Hobart, Peter M ^a   Barnhart, Kerry M ^a  

^a VICAL INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FURIN; INSULIN; PLASMID DNA; PROINSULIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SYNTHESIS; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DNA; DRUG DELIVERY SYSTEMS; FURIN; HUMANS; IMMUNOCOMPROMISED HOST; INJECTIONS, INTRAMUSCULAR; INSULIN; MICE; MICE, INBRED BALB C; MICE, NUDE; MUSCLE, SKELETAL; MUTATION; PLASMIDS; PROINSULIN; PROTEIN PRECURSORS; RATS; SUBTILISINS; TRANSFECTION;

ANIMALIA; MUS MUSCULUS;

EID: 0033231103     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950016672     Document Type: Article

References (63)

1. AIHARA, H., and MIYAZAKI, J. (1998). Gene transfer into muscle by electroporation in vivo. Nature Biotechnol. 16, 867-870.
2. ALILA, H., COLEMAN, M., NITTA, H., FRENCH, M., ANSWER, K., LIU, Q., MEYER, T., WANG, J., MUMPER, R., OUBARI, D., LONG, S., NORDSTROM, J., and ROLLAND, A. (1997). Expression of biologically active human insulin-like growth factor-I following intramuscular injection of a formulated plasmid in rats. Hum. Gene Ther. 8, 1785-1795.
3. ANWER, K., SHI, M., FRENCH, M.F., MULLER, S.R., CHEN, W., LIU, Q., PROCTOR, B.L., WANG, J., MUMPER, R.J., SINGHAL, A., ROLLAND, A.P., and ALILA, H.W. (1998). Systemic effect of human growth hormone after intramuscular injection of a single dose of a muscle-specific gene medicine. Hum. Gene Ther. 9, 659-670.
4. BEBOK, Z., ABAI, A.M., DONG, J.Y., KING, S.A., KIRK, K.L., BERTA, G., HUGHES, B.W., KRAFT, A.S., BURGESS, S.W., SHAW, W., FELGNER, P.L., and SORCHER, E.J. (1996). Efficiency of plasmid delivery and expression after lipid-mediated gene transfer to human cells in vitro. J. Pharmacol. Exp. Ther. 279, 1462-1469.
5. BREMS, D.N., BROWN, P.L., BRYANT, C., CHANCE, R.E., GREEN, L.K., LONG, H.B., MILLER, A.A., MILLICAN, R., SHIELDS, J.E., and FRANK, B.H. (1992). Improved insulin stability through amino acid substitution. Protein Eng. 5, 519-525.
6. BURKE, G.T., HU, S.Q., OHTA, N., SCHWARTZ, G.P., ZONG, L., and KATSOYANNIS, P.G. (1990). Superactive insulins. Biochem. Biophys. Res. Commun. 173, 982-987.
7. DOH, S.G., VAHLSING, H.L., HARTIKKA, J., LIANG, X., and MANTHORPE, M. (1997). Spatial-temporal patterns of gene expression in mouse skeletal muscle after injection of LacZ plasmid DNA. Gene Ther. 4, 648-663.
8. FAZIO, V.M., FAZIO, S., RINALDI, M., CATANI, M.V., ZOTTI, S., CIAFRE, S.A., SERIPA, D., RICCI, G., and FARACE, M.G. (1994). Accumulation of human apolipoprotein-E in rat plasma after in vivo intramuscular injection of naked DNA. Biochem. Biophys. Res. Commun. 200, 298-305.
9. GOLDFINE, I., GERMAN, M.S., TSENG, H.C., WANG, J., BOLAFFI, J.L., CHEN, J.W., OLSON, D.C., and ROTHMAN, S.S. (1997). The endocrine secretion of human insulin and growth hormone by exocrine glands of the gastrointestinal tract. Nature Biotechnol. 15, 1378-1382.
10. GROSKREUTZ, D.J., SLIWKOWSKI, M.X., and GORMAN, C.M. (1994). Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin. J. Biol. Chem. 269, 6241-6245.
11. HALBAN, P.A. (1991). Structural domains and molecular lifestyles of insulin and its precursors in the pancreatic beta cell. Diabetologia 34, 767-778.
12. HALBAN, P.A. (1994). Proinsulin processing in the regulated and the constitutive secretory pathway. Diabetologia 37 (Suppl. 2), S65-S72.
13. HALBAN, P.A., and IRMINGER, J.-C. (1994). Sorting and processing of secretory proteins. Biochem. J. 299, 1-18.
14. HASAN, U., ABAI, A.M., HARPER, D.R., WREN, B.W., and MORROW, W.J.W. (1999). Nucleic acid immunization: Concepts and techniques associated with third generation vaccines. J. Immunol. Methods (in press).
15. HATSUZAWA, K., HOSAKA, M., NAKAGAWA, T., NAGASE, M., SHODA, A., MURAKAMI, K., and NAKAYAMA, K. (1990). Structure and expression of mouse furin, a yeast kex2-related protease. Lack of processing of coexpressed prorenin in GH4C1 cells. J. Biol. Chem. 265, 22075-22078.
16. HEATH, W.F., BELAGAJE, R.M., BROOKE, G.S., CHANCE, R.E., HOFFMANN, J.A., LONG, H.B., REAMS, S.G., ROUNDTREE, C., SHAW, W.N., SLIEKER, L.J., SUNDELL, K.L., and DIMARCHI, R.D. (1992). (A-B-C) human proinsulin, a novel insulin agonist and intermediate in the synthesis of biosynthetic human insulin. J. Biol. Chem. 267, 419-425.
17. HORN, N.A., MEEK, J.A., BUDAHAZI, G., and MARQUET, M. (1995). Cancer gene therapy using plasmid DNA: Purification of DNA for human clinical trials. Hum. Gene Ther. 6, 565-573.
18. HORTON, H.M., ANDERSON, D., HERNANDEZ, P., BARNHART, K.M., NORMAN, J.A., and PARKER, S.E. (1999). A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon alpha. Proc. Natl. Acad. Sci. U.S.A. 96, 1553-1558.
19. IDO, Y., VINDIGNI, A., CHANG, K., STRAMM, L., CHANCE, R., HEATH, W.F., DIMARCHI, R.D., DI CERA, E., and WILLIAMSON, J.R. (1997). Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 277, 563-566.
20. KANEDA, Y., IWAI, K., and UCHIDA, T. (1989). Introduction and expression of the human insulin gene in adult rat liver. J. Biol. Chem. 264, 12126-12129.
21. KANG, S., BRANGE, J., BURCH, A., VOLUND, A., and OWENS, D.R. (1991). Absorption kinetics and action profiles of subcutaneously administered insulin analogues (AspB9GluB27, AspB10, AspB28) in healthy subjects. Diabetes Care 14, 1057-1065.
22. KOERKER, D.J., SWEET, I.R., and BASKIN, D.G. (1990). Insulin binding to individual rat skeletal muscles. Am. J. Physiol. 259 (4 Pt. 1), E517-E523.
23. KOLODKA, T.M., FINEGOLD, M., MOSS, L., and WOO, S.L. (1995). Gene therapy for diabetes mellitus in rats by hepatic expression of insulin. Proc. Natl. Acad. Sci. U.S.A. 92, 3293-3297.
24. LEVY, M.Y., BARRON, L.G., MEYER, K.B., and SZOKA, F.C., JR. (1996). Characterization of plasmid DNA transfer into mouse skeletal muscle: Evaluation of uptake mechanism, expression and secretion of gene products into blood. Gene Ther. 3, 201-211.
25. LIPES, M.A., DAVALLI, A.M., and COOPER, E.M. (1997). Genetic engineering of insulin expression in nonislet cells: Implications for beta cell replacement therapy for insulin-dependent diabetes mellitus. Acta Diabetol. 34, 2-5.
26. MA, J.X., YANG, Z., CHAO, J., and CHAO, L. (1995). Intramuscular delivery of rat kallikrein-binding protein gene reverses hypotension in transgenic mice expressing human tissue kallikrein. J. Biol. Chem. 270, 451-455.
27. MANTHORPE, M., HARTIKKA, J., VAHLSING, H.L., and SAWDEY, M. (1999). Quantification of plasmid DNA expression in vivo. In Gene Quantification. F. Ferre, ed. (Birkhäuser, Cambridge, MA) pp. 1-23. (in press.)
28. MILLER, G., STEINBRECHER, R.A., MURDOCK, P.J., TUDDENHAM, E.G., LEE, C.A., PASI, K.J., and GOLDSPINK, G. (1995). Expression of factor VII by muscle cells in vitro and in vivo following direct gene transfer: Modelling gene therapy for haemophilia. Gene Ther. 2, 736-742.
29. MITANCHEZ, D., CHEN, R., MASSIAS, J.F., PORTEU, A., MIGNON, A., BERTAGNA, X., and KAHN, A. (1998). Regulated expression of mature human insulin in the liver of transgenic mice. FEBS Lett. 421, 285-289.
30. MUZZIN, P., EISENSMITH, R.C., COPELAND, K.C., and WOO, S.L. (1997). Hepatic insulin gene expression as treatment for type 1 diabetes mellitus in rats. Mol. Endocrinol. 11, 833-837.
31. NAKAYAMA, K. (1997). Furin: A mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem. J. 327, 625-635.
32. NICOLAU, C., LE PEPE, A., SORIANO, P., FERGETTE, F., MUH, J.P., and JUHEL, M.F. (1982). In vivo transfer and expression of the liposome encapsulated rat insulin gene. Prog. Clin. Biol. Res. 102(Pt. A), 321-330.
33. NIELSEN, F.S., JORGENSEN, L.N., IPSEN, M., VOLDSGAARD, A.I., and PARVING, H.H. (1995). Long-term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen. Diabetologia 38, 592-598.
34. NITTA, Y., TASHIRO, F., TOKUI, M., SHIMADA, A., TAKEI, I., TABAYASHI, K., and MIYAZAKI, J. (1998). Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice. Hum. Gene Ther. 9, 1701-1707.
35. NOVO, F.J., GORECKI, D.C., GOLDSPINK, G., and MACDERMOT, K.D. (1997). Gene transfer and expression of human alpha-galactosidase from mouse muscle in vitro and in vivo. Gene Ther. 4, 488-492.
36. OLEFSKY, J., BACON, V.C., and BAUR, S. (1976). Insulin receptors of skeletal muscle: Specific insulin binding sites and demonstration of decreased numbers of sites in obese rats. Metabolism 25, 179-191.
37. POLONSKY, K.S. (1995). Lilly Lecture 1994. The beta-cell in diabetes: From molecular genetics to clinical research. Diabetes 44, 705-717.
38. RAKIETEN, N., RAKIETEN, M.L., and NADKARNI, M.V. (1963). Studies on the diabetogenic action of streptozotocin. Cancer Chemother. Rep. 29, 91.
39. RAZ, E., WATANABE, A., BAIRD, S.M., EISENBERG, R.A., PARR, T.B., LOTZ, M., KIPPS, T.J., and CARSON, D.A. (1993). Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 90, 4523-4527.
40. RAZ, E., DUDLER, J., LOTZ, M., BAIRD, S.M., BERRY, C.C., EISENBERG, R.A., and CARSON, D.A. (1995). Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery. Lupus 4, 286-292.
41. REFERS, R.R., HENRY, R., SCHMEISER, L., KOLTERMAN, O., COHEN, R., BERGENSTAL, R., POLONSKY, K., JASPAN, J., RUBENSTEIN, A., FRANK, B., GALLOWAY, J., and OLEFSKY, J.M. (1984). The effects of biosynthetic human proinsulin on carbohydrate metabolism. Diabetes 33, 762-770.
42. SANTIAGO, J.V. (1993). Lessons from the Diabetes Control and Complications Trial. Diabetes 42, 1549-1554.
43. SCHWARTZ, G.P., BURKE, G.T., and KATSOYANNIS, P.G. (1987). A superactive insulin: [B10-aspartic acid] insulin (human). Proc. Natl. Acad. Sci. U.S.A. 84, 6408-6411.
44. SHORT, D.K., OKADA, S., YAMAUCHI, K., and PESSIN, J.E. (1998). Adenovirus-mediated transfer of a modified human proinsulin gene reverses hyperglycemia in diabetic mice. Am. J. Physiol. 275, E748-E756.
45. SIMONSON, G.D., GROSKREUTZ, D.J., GORMAN, C.M., and MACDONALD, M.J. (1996). Synthesis and processing of genetically modified human proinsulin by rat myoblast primary cultures. Hum. Gene Ther. 7, 71-78.
46. SINDELAR, D.K., CHU, C.A., VENSON, P., DONAHUE, E.P., NEAL, D.W., and CHERRINGTON, A.D. (1998). Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes 47, 523-529.
47. SMEEKENS, S.P., MONTAG, A.G., THOMAS, G., ALBIGES-RIZO, C., CARROLL, R., BENIG, M., PHILLIPS, L.A., MARTIN, S., OHAGI, S., GARDNER, P., SWIFT, H.H., and STEINER, D.F. (1992). Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3. Proc. Natl. Acad. Sci. U.S.A. 89, 8822-8826.
48. STEINER, D.F., TAGER, H.S., CHAN, S.J., NANJO, K., SANKE, T., and RUBENSTEIN, A.H. (1990). Lessons learned from molecular biology of insulin-gene mutations. Diabetes Care 13, 600-609.
49. STEWART, C., TAYLOR, N.A., DOCHERTY, K., and BAILEY, C.J. (1993). Insulin delivery by somatic cell gene therapy. J. Mol. Endocrinol. 11, 335-341.
50. SUGIYAMA, A., HATTORI, S., TANAKA, S., ISODA, F., KLEOPOULOS, S., ROSENFELD, M., KAPLITT, M., SEKIHARA, H., and MOBBS, C. (1997). Defective adenoassociated viral-mediated transfection of insulin gene by direct injection into liver parenchyma decreases blood glucose of diabetic mice. Horm. Metab. Res. 29, 599-603.
51. TAYLOR, S.I. (1995). Diabetes mellitus. In The Metabolic and Molecular Bases of Inherited Disease. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, J.B. Stanbury, J.B. Wyngaarden, and D.S. Frederickson, eds. (McGraw-Hill, New York) pp. 843-896.
52. TOKUI, M., TAKEI, I., TASHIRO, F., SHIMADA, A., KASUGA, A., ISHII, T., TAKATSU, K., SARUTA, T., and MIYAZAKI, J. (1997). Intramuscular injection of expression plasmid DNA is an effective means of long-term systemic delivery of interleukdn-5. Biochem. Biophys. Res. Commun. 233, 527-531.
53. TRIPATHY, S.K., SVENSSON, E.C., BLACK, H.B., GOLDWASSER, E., MARGALITH, M., HOBART, P.M., and LEIDEN, J.M. (1996). Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Proc. Natl. Acad. Sci. U.S.A. 93, 10876-10880.
54. ULMER, J.B., DONNELLY, J.J., PARKER, S.E., RHODES, G.H., FELGNER, P.L., DWARKI, V.J., GROMKOWSKI, S.H., DECK, R.R., FRIEDMAN, A., and LIU, M. (1993). Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749. UNITED STATES PHARMACOPEIA NATIONAL FORMULARY (1995). USP23, NF 18 (Rand McNally, Taunton, MA) pp. 1716-1717
55. ULMER, J.B., DONNELLY, J.J., PARKER, S.E., RHODES, G.H., FELGNER, P.L., DWARKI, V.J., GROMKOWSKI, S.H., DECK, R.R., FRIEDMAN, A., and LIU, M. (1993). Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749. UNITED STATES PHARMACOPEIA NATIONAL FORMULARY (1995). USP23, NF 18 (Rand McNally, Taunton, MA) pp. 1716-1717
56. UNITED STATES PHARMACOPEIA NATIONAL FORMULARY (1995). USP 23, NF 18 (Rand McNally, Taunton, MA) pp. 1716-1717.
57. VALERA, A., PILLAT, C., COSTA, C., SABATER, J., VISA, J., PUJOL, A., and BOSCH, F. (1994). Regulated expression of human insulin in the liver of transgenic mice corrects diabetic alterations. FASEB J. 8, 440-447.
58. VOLLENWEIDER, F., KAUFMANN, J., IRMINGER, J.C., and HALBAN, P.A. (1995). Processing of proinsulin by furin, PC2, and PC3 in (co)transfected COS (monkey kidney) cells. Diabetes 44, 1075-1080.
59. WANG, C. (1986). Purification and autophosphorylation of insulin receptors from rat skeletal muscle. Biochim. Biophys. Acta 888, 107-115.
60. WOLFF, J.A., MALONE, R.W., WILLIAMS, P., CHONG, W., ACSADI, G., JANI, A., and FELGNER, P.L. (1990). Direct gene transfer into mouse muscle in vivo. Science 247, 1465-1468.
61. YAJIMA, H., KOSUKEGAWA, A., HOQUE, M.M., SHIMOJIMA, T., ISHIZU, K., TAKAYAMA, M., SASAKI, Y., SAKAI, H., OTSUKA, M., INOKUCHI, S., and HANDA, H. (1996). Construction and characterization of a recombinant adenovirus carrying the human preproinsulin gene under control of the metallothionein gene promoter. Biochem. Biophys. Res. Commun. 229, 778-787.
62. YANAGITA, M., NAKAYAMA, K., and TAKEUCHI, T. (1992). Processing of mutated proinsulin with tetrabasic cleavage sites to bioactive insulin in the non-endocrine cell line, COS-7. FEBS Lett. 311, 55-59.
63. YANAGITA, M., HOSHINO, H., NAKAYAMA, K., and TAKEUCHI, T. (1993). Processing of mutated proinsulin with tetrabasic cleavage sites to mature insulin reflects the expression of furin in non-endocrine cell lines. Endocrinology 133, 639-644.